German Helios purchase Cheiron Health by EUR 5,760 million
The transaction, subject to approval of the European authorities
competition, would close in the fourth quarter of this year or the first
2017.
The German healthcare group Fresenius Helios has reached an agreement with the
Spanish Cheiron Health to buy for 5,760 million euros. the resulting
It would be the first cluster of the sector in Europe and one of the most important
the world have informed both parties.
The new group will have more than 100,000 employees, managed by 155 centers
health and maintain both brands, Cheiron Health and Helios in Spain
Germany. The transaction, subject to approval by the European authorities
competition, would close in the fourth quarter of this year or the first
2017.
Fresenius Helios, founded in 1912, is the largest European healthcare group,
more than 220,000 employees in one hundred countries and a market capitalization close to
36,000 million euros. Opera in the American markets, where he develops
45% of its activity, European (39%) and Asia (10%).
With this operation, the British venture capital fund CVC will be replaced
as shareholder in the new group for Helios. German tells his
once as the main shareholder with a non-profit foundation, Else
Kröner-Fresenius-Stiftung, dedicated to medical research and development
medical and humanitarian projects.
The management of Chiron Health will continue in the hands of the current team, which
will be integrated into the new company to be part of the consolidation project
international. In this sense, Chiron Health projects directed to
Latin America.
Five Days
Published on Monday, 5 September 2016
No comments:
Post a Comment